TOP1210

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/01/2016 - "Targeted, multikinase inhibition with TOP1210 leads to a broad efficacy profile in both the innate and adaptive immune responses, with significant advantages over existing selective kinase approaches, and potentially offers a much improved therapeutic benefit in inflammatory bowel disease."
2.	Ulcerative Colitis 01/01/2016 - "The activity of a narrow spectrum kinase inhibitor, TOP1210, has been compared with selective kinase inhibitors (BIRB-796, dasatinib and BAY-61-3606) in a range of kinase assays, inflammatory cell assays, and in inflamed biopsies from patients with ulcerative colitis (UC). "

1.	Phosphotransferases (Kinase)